The signal backscattered by blood cells crossing a sample volume produces a Doppler power spectrum determined by the scatterers¿ velocity distribution. Because of intrinsic spectral broadening, the peak Doppler frequency observed does not correspond to the peak velocity in the flow. Several methods have been proposed for estimating the maximum velocity component--an important clinical parameter--but these methods are approximate, based on heuristic thresholds that can be inaccurate and strongly affected by noise. Reported here is a method of modeling the Doppler power spectrum of a flow, and from that model, determining what Doppler frequency on the descending slope of the power spectrum corresponds to the peak velocity in the insonated flow. It is shown that, for a fully insonated flow with a parabolic velocity distribution, the peak velocity corresponds to the Doppler frequency at the half-power point on that slope. The method is demonstrated to be robust with regard to the effects of noise and valid for a wide range of acquisition parameters. Experimental maximum velocity measurements on steady flows with rates between 100 and 300 mL/min (peak velocity range 6.6 cm/s to 19.9 cm/s) show a mean bias error that is smaller than 1%.
Catheters and other interventional medical devices are presently guided by X-ray imaging, despite the advantages of ultrasound imaging over X-ray imaging in cost, safety, and availability. X-ray imaging is used because ultrasound reflects specularly from catheters and similar devices; their visibility is highly angle-dependent. With an omni-directional receiver mounted on a device, the receiver's location in the ultrasound image can be deduced from knowing which acoustic ray struck the receiver and the time from transmission of the imaging pulse to its reception by the receiver. This information is independent of specular reflection. The location of the device can then be indicated in the ultrasound image by an arrow pointing to the sensor, making possible ultrasound guidance of these devices. This paper describes the technical and practical considerations in the design and construction of the device-mounted receiver and associated electronics, and describes some clinical uses.
Ultrasound blood peak velocity estimates are routinely used for diagnostics, such as the grading of a stenosis. The peak velocity is typically assessed from the Doppler spectrum by locating the highest frequency detectable from noise. The selected frequency is then converted to velocity by the Doppler equation. This procedure contains several potential sources of error: the frequency selection is noise dependent and sensitive to the spectral broadening, which, in turn, is affected by the Doppler angle uncertainty. The result is, often, an inaccurate estimate. In this work we propose a new method that removes the aforementioned errors. The frequency is selected by exploiting a mathematical model of the Doppler spectrum that has recently been introduced. When a very large sample volume is used, which includes all the vessel section, the model is capable of predicting the exact threshold to be used without the need of broadening compensation. The angle ambiguity is solved by applying the threshold to the Doppler spectra measured from two different directions, according to the vector Doppler technique. The proposed approach has here been validated through Field II simulations, phantom experiments, and tests on volunteers by using defocused waves to insonify a large region from a linear array probe. A mean error lower than 1% and a mean coefficient of variability lower than 5% were measured in a variety of experimental conditions.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.